Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo (Q73339600)
scientific article published on 01 September 1999
Language:
(P31) (Q13442814)
(P304) 3809-3816
(P407) (Q1860)
(P433) 5B
(P478) 19
(P577) Wednesday, September 1, 1999
(P921) (Q18556145)
(Q15303190)
(P1433) (Q326290)
(P1476) "Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo" (language: en)
(P2093) Della Porta P
Soeltl R
Krell HW
Collins K
O'Donoghue M
Schmitt M
Krüger A
other details
description scientific article published on 01 September 1999

External Links